
Kimia Biosciences Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns
2026-03-03 08:10:56Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 2 March 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s long-term growth prospects remain subdued, compounded by high leverage and underperformance relative to the broader market.
Read full news article
Kimia Biosciences Ltd is Rated Sell
2026-03-02 10:10:49Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Kimia Biosciences Ltd is Rated Sell
2026-02-19 10:11:15Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 19 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleAre Kimia Biosciences Ltd latest results good or bad?
2026-02-14 19:37:42Kimia Biosciences Ltd's latest financial results reflect a complex operational landscape. In Q2 FY26, the company reported net sales of ₹34.00 crores, achieving a sequential growth of 44.19% compared to the previous quarter and a year-on-year increase of 20.65%. However, this revenue growth did not translate into proportional profitability, as net profit stood at ₹1.02 crores, which is a significant decline of 36.65% year-on-year, despite a 70% increase quarter-on-quarter. The operating margin for the quarter decreased to 7.41%, marking the lowest level in recent periods, down from 10.73% in the previous quarter and 11.96% a year ago. This contraction indicates ongoing challenges in maintaining operational efficiency amid rising costs or pricing pressures. Additionally, the company faced negative other income of ₹0.33 crores, contrasting with positive other income in the previous quarter, which further imp...
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-02-08 10:10:41Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-01-28 10:10:51Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-01-05 10:15:12Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2025-12-25 12:58:29Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read full news articleAnnouncement under Regulation 30 (LODR)-Resignation of Director
19-Feb-2026 | Source : BSEResignation of Additional Director(in the category of Executive Director)
Announcement under Regulation 30 (LODR)-Newspaper Publication
19-Feb-2026 | Source : BSENewspaper Publication-Postal ballot
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
18-Feb-2026 | Source : BSEIntimation of postal ballot notice
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






